1van den Boogaard J, Boeree MJ, Kibiki GS, et al. The complex- ity of the adherence-response relationship in tuberculosis treat ment: why are we still in the dark and how can we get out? Trop Med Int Health,2011,16(6) :693-698.
2AI Hajjaj MS, AI Khatim IM. High rate of noncompliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. Int J Tuberc Lung Dis,2000,4(4):345-349.
3Nezenega ZS, Oaeho YH, Tafere TE. Patient satisfaction on tuberculosis treatment service and adherence to treatment in public health facilities of Sidama zone, South Ethiopia. BMC Health Serv Res, 2013,13 : 110.
4World Health Organization. The Stop TB Strategy. building on and enhancing DOTS to meet the TPrrelated Millennium Development Goals. WHO/HTM/STB/2006.37. Geneva: World Health Organization, 2006.
5Garrido Mda S, Penna ML,Perez-Porcuna TM, et al. Factors associated with tuberculosis treatment default in an endemic area of the Brazilian Amazon: a case control-study. PLoS One,2012,7(6) :e39134.
6Pasipanodya JG, Gumbo T. A meta-analysis of self-adminis tered vs directly observed therapy effect on microbiologic fail- ure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infect Dis, 2013,57(1) : 21-31.
7Volmink J,Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev, 2007, (4) :CD003343.
8Belknap R,Weis S,Brookens A, et al. Feasibility of an ingesti- ble sensor-based system for monitoring adherence to tuberculo sis therapy. PLoS One,2013,8(1) :e53373.
9Au-Yeung KY,DiCarlo I. Cost comparison of wirelessly vs. directly observed therapy for adherence confirmation in anti-tu berculosis treatment. Int J Tuberc Lung Dis, 2012, 16 (11) : 1498-1504.
10Kunawararak P,Pongpanich S,Chantawong S, et al. Tubercu- losis treatment with mobile-phone medication reminders in northern Thailand. Southeast Asian J Trop Med Public Health, 2011,42(6) : 1444-1451.
